- Previous close
257.83 - Open
259.07 - Bid 259.67 x 800
- Ask 260.71 x 800
- Day's range
258.17 - 265.00 - 52-week range
213.31 - 527.18 - Volume
1,180,642 - Avg. Volume
2,105,281 - Market cap (intra-day)
31.392B - Beta (5Y monthly) 0.50
- PE ratio (TTM)
22.73 - EPS (TTM)
11.47 - Earnings date 23 Jan 2025 - 27 Jan 2025
- Forward dividend & yield 3.54 (1.36%)
- Ex-dividend date 31 Dec 2024
- 1y target est
289.83
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
www.humana.com67,600
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Healthcare Plans
Industry
Recent news: HUM
View more
Performance overview: HUM
Trailing total returns as of 01/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: HUM
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: HUM
View moreValuation measures
Market cap
31.39B
Enterprise value
39.30B
Trailing P/E
22.75
Forward P/E
13.68
PEG ratio (5-yr expected)
1.08
Price/sales (ttm)
0.28
Price/book (mrq)
1.79
Enterprise value/revenue
0.34
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
1.18%
Return on assets (ttm)
4.01%
Return on equity (ttm)
7.84%
Revenue (ttm)
115.01B
Net income avi to common (ttm)
1.36B
Diluted EPS (ttm)
11.47
Balance sheet and cash flow
Total cash (mrq)
24.15B
Total debt/equity (mrq)
75.91%
Levered free cash flow (ttm)
-10.63B